Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy?

Scientists treating depression and a range of other mental illnesses have been running controlled trials using MDMA and psychedelic drugs such as LSD and the results have been encouraging

Aside from the profound immediate health challenges of the global pandemic, many countries in recent years have had huge increases in numbers of people presenting with depression and other mental illnesses. In the UK, prescriptions for antidepressants has more than doubled in the past decade.

, Ecstasy, LSD and magic mushrooms: are these drugs the future of therapy?, The Nzuchi Times Guardian

This huge demand has meant opportunities for research into all sorts of possible treatments for mental illnesses and for Robin Carhart-Harris that has meant groundbreaking investigations into the possible therapeutic uses of psychedelics and other controlled substances. The mind-altering properties of drugs such as ecstasy, LSD and magic mushrooms are well known, but their usefulness to medicine has until now not been the subject of rigorous medical trials. The early results are encouraging. Robin tells Rachel Humphreys how he has been leading work showing how psilocybin ( or magic mushrooms) can be used to assist psychotherapy for difficult-to-treat depression, making a significant difference where conventional antidepressants and talking therapy have not.

Continue reading…

More Stories
Boris Becker: ‘When I was winning at Wimbledon it was no “blitzkrieg”’